Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15
Original Research
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,446 | Dovepress* | 7,533+ | 670 | 8,203 | |
| PubMed Central* | 913 | 291 | 1,204 | ||
| Totals | 8,446 | 961 | 9,407 | ||
| *Since 3 December 2020 | |||||
View citations on PubMed Central and Google Scholar